Health
New anti-cancer drug breakthrough for prostate cancer – Mirage News
Novel anti-cancer agents induce the degradation of the c-Met oncoprotein in the lysosome as demonstrated by confocal microscopy in tumour cells A new…
A new anti-cancer drug for prostate cancer overcomes the twin problems plaguing researchers for decades. It halts metastasis (tumour spread) and drug resistance.
Developed by Griffith University researcher Professor Des Richardson and colleagues from the University of Sydney, the drug known as DpC inhibits prostate specific antigen (PSA) as well as suppressing both androgen-dependent and independent arms of androgen receptor signalling.
“The current gold standard for prostate cancer treatment …
-
General18 hours agoElon Musk deletes post claiming Donald Trump is ‘in the Epstein files’
-
General16 hours agoVance downplays row between Trump, ’emotional guy’ Musk
-
Noosa News12 hours agoElectrify your vehicle, home or business at Noosa’s EV & Electrify Everything Expo
-
General24 hours agoLabor’s communism must be destroyed